Article Text
Abstract
The paper proposes a new method of researching public opinion for the purposes of valuing the outcomes of healthcare interventions. The issue I address is that, under the quality-adjusted life-year system, disabled patients face a higher cost-effectiveness hurdle than able-bodied patients. This seems inequitable. The author considers the alternative approaches to valuing healthcare interventions that have been proposed, and shows that all of them face the same problem. It is proposed that to value an outcome, instead of researching the general public, the population that is to be targeted with the intervention should be researched.
- Allocation of healthcare resources
- cost-effectiveness
- disability
- discrimination
- equality
- health economics
- health technology assessment
- healthcare economics
- healthcare resource allocation
- NICE
- philosophical ethics
- QALY
- quality of life
- quality/value of life/personhood
- value
Statistics from Altmetric.com
Footnotes
Competing interests SCS conducts market research and opinion research for pharmaceutical companies and healthcare providers.
Provenance and peer review Not commissioned; externally peer reviewed.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
Linked Articles
- The concise argument
Read the full text or download the PDF:
Other content recommended for you
- Capabilities and health
- How do adults with physical disability experience primary care? A nationwide cross-sectional survey of access among patients in England
- NICE is not cost effective
- The use of cost - effectiveness by the National Institute for Health and Clinical Excellence (NICE): no (t yet an) exemplar of a deliberative process
- Not a NICE fallacy: a reply to Dr Quigley
- Ageism and equality
- National Institute for Health and Clinical Excellence appraisal and ageism
- NICE ’s end of life decision making scheme: impact on population health
- Wickedness or folly? The ethics of NICE ’s decisions
- NICE and neurology